99mTc-MAG3-aptamer for imaging human tumors associated with high level of matrix metalloprotease-9

Bioconjugate Chemistry

Volumn 23, Issue 11, 2012, Pages 2192-2200

  Da Rocha Gomes, Sonia ^a,b,f   Miguel, Julie ^d   Azéma, Laurent ^a,b   Eimer, Sandrine ^b,d   Ries, Colette ^b,c   Dausse, Eric ^a,b   Loiseau, Hugues ^b,d   Allard, Michèle ^b,c,d,e   Toulmé, Jean Jacques ^a,b  

^a INSERM U869   (France)

^b UNIVERSITÉ DE BORDEAUX   (France)

^c CNRS   (France)

^d BORDEAUX UNIVERSITY HOSPITAL   (France)

^e PSL RESEARCH UNIVERSITY   (France)

^f Novaptech   (France)

Author keywords

[No Author keywords available]

Indexed keywords

SURFACE PLASMON RESONANCE; TUMORS;

APTAMERS; BINDING PROPERTIES; CANCER CELLS; HUMAN MATRIX; HUMAN TUMORS; MATRIX METALLOPROTEASE; OVEREXPRESSIONS; PHYSIOLOGICAL PROCESS; RIBONUCLEOSIDES; TISSUE REMODELING;

BINDING ENERGY;

APTAMER; GELATINASE A; GELATINASE B; MATRILYSIN; MERTIATIDE TC 99M; NUCLEASE; RIBONUCLEOSIDE; S ACETYLMERCAPTOACETYLTRIGLYCINE; TRIGLYCINE; UNCLASSIFIED DRUG;

ARTICLE; BINDING AFFINITY; BRAIN TUMOR; CENTRAL NERVOUS SYSTEM TUMOR; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; ISOTOPE LABELING; NEUROIMAGING; PROTON NUCLEAR MAGNETIC RESONANCE; SURFACE PLASMON RESONANCE;

EID: 84869750251     PISSN: 10431802     EISSN: 15204812     Source Type: Journal    
DOI: 10.1021/bc300146c     Document Type: Article

References (53)

1. Louis, D. N., Ohgaki, H., Wiestler, O. D., Cavenee, W. K., Burger, P. C., Jouvet, A., Schelthauer, B. W., and Kleihues, P. (2007) The 2007 WHO classification of tumours of the central nervous system Acta Neuropathol. 114, 97-109
2. Laperriere, N., Zuraw, L., and Cairncross, G. (2002) Radiotherapy for newly diagnosed malignant glioma in adults: a systematic review Radiother. Oncol. 64, 259-73
3. Heimberger, A. B., McGary, E. C., Suki, D., Ruiz, M., Wang, H., Fuller, G. N., and Bar-Eli, M. (2005) Loss of the AP-2alpha transcription factor is associated with the grade of human gliomas Clin. Cancer Res. 11, 267-72
4. Rao, J. S. (2003) Molecular mechanisms of glioma invasiveness: the role of proteases Nat. Rev. Cancer 3, 489-501
5. Stamenkovic, I. (2003) Extracellular matrix remodelling: the role of matrix metalloproteinases J. Pathol. 200, 448-64
6. Binder, D. K. and Berger, M. S. (2002) Proteases and the biology of glioma invasion J. Neurooncol. 56, 149-58
7. Auge, F., Hornebeck, W., and Laronze, J. Y. (2004) A novel strategy for designing specific gelatinase A inhibitors: potential use to control tumor progression Crit. Rev. Oncol. Hematol. 49, 277-82
8. Bachmeier, B. E., Iancu, C. M., Jochum, M., and Nerlich, A. G. (2005) Matrix metalloproteinases in cancer: comparison of known and novel aspects of their inhibition as a therapeutic approach Expert Rev. Anticancer Ther. 5, 149-63
9. Forget, M. A., Desrosiers, R. R., and Beliveau, R. (1999) Physiological roles of matrix metalloproteinases: implications for tumor growth and metastasis Can. J. Physiol. Pharmacol. 77, 465-80
10. Tuerk, C. and Gold, L. (1990) Systematic evolution of ligands by exponential enrichment: RNA ligands to bacteriophage T4 DNA polymerase Science 249, 505-10
11. Ellington, A. D. and Szostak, J. W. (1990) In vitro selection of RNA molecules that bind specific ligands Nature 346, 818-22
12. Robertson, D. L. and Joyce, G. F. (1990) Selection in vitro of an RNA enzyme that specifically cleaves single-stranded DNA Nature 344, 467-8
13. Mayer, G. (2009) The chemical biology of aptamers Angew. Chem., Int. Ed. Engl. 48, 2672-89
14. Syed, M. A. and Pervaiz, S. (2010) Advances in aptamers Oligonucleotides 20, 215-24
15. Soontornworajit, B. and Wang, Y. (2011) Nucleic acid aptamers for clinical diagnosis: cell detection and molecular imaging Anal. Bioanal. Chem. 399, 1591-9
16. Dausse, E., Da Rocha Gomes, S., and Toulmé, J. J. (2009) Aptamers: a new class of oligonucleotides in the drug discovery pipeline? Curr. Opin. Pharmacol. 9, 602-7
17. Gomes, S. D. R., Azéma, L., Allard, M., and Toulmé, J. J. (2010) Aptamers as imaging agents Expert Opinion on Medical Diagnostics 4, 511-518
18. Charlton, J., Sennello, J., and Smith, D. (1997) In vivo imaging of inflammation using an aptamer inhibitor of human neutrophil elastase Chem. Biol. 4, 809-16
19. Lupold, S. E., Hicke, B. J., Lin, Y., and Coffey, D. S. (2002) Identification and characterization of nuclease-stabilized RNA molecules that bind human prostate cancer cells via the prostate-specific membrane antigen Cancer Res. 62, 4029-33
20. Hicke, B. J., Stephens, A. W., Gould, T., Chang, Y. F., Lynott, C. K., Heil, J., Borkowski, S., Hilger, C. S., Cook, G., Warren, S., and Schmidt, P. G. (2006) Tumor targeting by an aptamer J. Nucl. Med. 47, 668-78
21. Shangguan, D., Li, Y., Tang, Z., Cao, Z. C., Chen, H. W., Mallikaratchy, P., Sefah, K., Yang, C. J., and Tan, W. (2006) Aptamers evolved from live cells as effective molecular probes for cancer study Proc. Natl. Acad. Sci. U. S. A. 103, 11838-43
22. Herr, J. K., Smith, J. E., Medley, C. D., Shangguan, D., and Tan, W. (2006) Aptamer-conjugated nanoparticles for selective collection and detection of cancer cells Anal. Chem. 78, 2918-24
23. Borbas, K. E., Ferreira, C. S., Perkins, A., Bruce, J. I., and Missailidis, S. (2007) Design and synthesis of mono- and multimeric targeted radiopharmaceuticals based on novel cyclen ligands coupled to anti-MUC1 aptamers for the diagnostic imaging and targeted radiotherapy of cancer Bioconjugate Chem. 18, 1205-12
24. Phillips, J. A., Lopez-Colon, D., Zhu, Z., Xu, Y., and Tan, W. (2008) Applications of aptamers in cancer cell biology Anal. Chim. Acta 621, 101-8
25. Li, W., Yang, X., Wang, K., Tan, W., He, Y., Guo, Q., Tang, H., and Liu, J. (2008) Real-time imaging of protein internalization using aptamer conjugates Anal. Chem. 80, 5002-8
26. Sefah, K., Tang, Z. W., Shangguan, D. H., Chen, H., Lopez-Colon, D., Li, Y., Parekh, P., Martin, J., Meng, L., Phillips, J. A., Kim, Y. M., and Tan, W. H. (2009) Molecular recognition of acute myeloid leukemia using aptamers Leukemia 23, 235-44
27. Smith, J. E., Medley, C. D., Tang, Z., Shangguan, D., Lofton, C., and Tan, W. (2007) Aptamer-conjugated nanoparticles for the collection and detection of multiple cancer cells Anal. Chem. 79, 3075-82
28. Medley, C. D., Bamrungsap, S., Tan, W., and Smith, J. E. (2011) Aptamer-conjugated nanoparticles for cancer cell detection Anal. Chem. 83, 727-34
29. Ko, H. Y., Choi, K. J., Lee, C. H., and Kim, S. (2011) A multimodal nanoparticle-based cancer imaging probe simultaneously targeting nucleolin, integrin alphavbeta3 and tenascin-C proteins Biomaterials 32, 1130-8
30. Zhou, J., Soontornworajit, B., and Wang, Y. (2010) A temperature- responsive antibody-like nanostructure Biomacromolecules 11, 2087-93
31. Blank, M., Weinschenk, T., Priemer, M., and Schluesener, H. (2001) Systematic evolution of a DNA aptamer binding to rat brain tumor microvessels. selective targeting of endothelial regulatory protein pigpen J. Biol. Chem. 276, 16464-8
32. Farokhzad, O. C., Jon, S., Khademhosseini, A., Tran, T. N., Lavan, D. A., and Langer, R. (2004) Nanoparticle-aptamer bioconjugates: a new approach for targeting prostate cancer cells Cancer Res. 64, 7668-72
33. Shangguan, D., Meng, L., Cao, Z. C., Xiao, Z., Fang, X., Li, Y., Cardona, D., Witek, R. P., Liu, C., and Tan, W. (2008) Identification of liver cancer-specific aptamers using whole live cells Anal. Chem. 80, 721-8
34. Li, S., Xu, H., Ding, H., Huang, Y., Cao, X., Yang, G., Li, J., Xie, Z., Meng, Y., Li, X., Zhao, Q., Shen, B., and Shao, N. (2009) Identification of an aptamer targeting hnRNP A1 by tissue slide-based SELEX J. Pathol. 218, 327-36
35. Zhang, Z., Guo, L., Guo, A., Xu, H., Tang, J., Guo, X., and Xie, J. (2010) In vitro lectin-mediated selection and characterization of rHuEPO-alpha-binding ssDNA aptamers Bioorg. Med. Chem. 18, 8016-25
36. Shi, H., He, X., Wang, K., Wu, X., Ye, X., Guo, Q., Tan, W., Qing, Z., Yang, X., and Zhou, B. (2011) Activatable aptamer probe for contrast-enhanced in vivo cancer imaging based on cell membrane protein-triggered conformation alteration Proc. Natl. Acad. Sci. U. S. A. 108, 3900-5
37. Sousa, R. and Padilla, R. (1995) A mutant T7 RNA polymerase as a DNA polymerase Embo J. 14, 4609-21
38. Bartel, D. P. and Szostak, J. W. (1994) Study of RNA-protein recognition by in vitro selection, in RNA-Protein interactions (Nagai, K. and Mattaj, I. W., Eds.) pp 248-268, IRL Press, Oxford.
39. McEntee, K., Weinstock, G. M., and Lehman, I. R. (1980) recA protein-catalysed strand assimilation: stimulation by Escherichia coli single-stranded DNA-binding protein Proc. Natl. Acad. Sci. U.S.A. 77, 857-61
40. Winnard, P., Jr., Chang, F., Rusckowski, M., Mardirossian, G., and Hnatowich, D. J. (1997) Preparation and use of NHS-MAG3 for technetium-99m labeling of DNA Nucl. Med. Biol. 24, 425-32
41. Di Primo, C., Dausse, E., and Toulme, J. J. (2011) Surface plasmon resonance investigation of RNA aptamer-RNA ligand interactions Methods Mol. Biol. 764, 279-300
42. Comincini, S., Paolillo, M., Barbieri, G., Palumbo, S., Sbalchiero, E., Azzalin, A., Russo, M. A., and Schinelli, S. (2009) Gene expression analysis of an EGFR indirectly related pathway identified PTEN and MMP9 as reliable diagnostic markers for human glial tumor specimens J. Biomed. Biotechnol. 2009, 924565
43. Das, G., Shiras, A., Shanmuganandam, K., and Shastry, P. (2010) Rictor regulates MMP-9 activity and invasion through Raf-1-MEK-ERK signaling pathway in glioma cells Mol. Carcinog. 50, 412-423
44. Lee, E. J., Kim, S. Y., Hyun, J. W., Min, S. W., Kim, D. H., and Kim, H. S. (2010) Glycitein inhibits glioma cell invasion through down-regulation of MMP-3 and MMP-9 gene expression Chem. Biol. Interact. 185, 18-24
45. Veeravalli, K. K., Chetty, C., Ponnala, S., Gondi, C. S., Lakka, S. S., Fassett, D., Klopfenstein, J. D., Dinh, D. H., Gujrati, M., and Rao, J. S. (2010) MMP-9, uPAR and cathepsin B silencing downregulate integrins in human glioma xenograft cells in vitro and in vivo in nude mice PLoS One 5, e11583
46. Bremer, C., Tung, C. H., and Weissleder, R. (2001) In vivo molecular target assessment of matrix metalloproteinase inhibition Nat. Med. 7, 743-8
47. Wallis de Vries, B. M., Hillebrands, J. L., van Dam, G. M., Tio, R. A., de Jong, J. S., Slart, R. H., and Zeebregts, C. J. (2009) Images in cardiovascular medicine. Multispectral near-infrared fluorescence molecular imaging of matrix metalloproteinases in a human carotid plaque using a matrix-degrading metalloproteinase-sensitive activatable fluorescent probe Circulation 119, e534-6
48. Furumoto, S., Takashima, K., Kubota, K., Ido, T., Iwata, R., and Fukuda, H. (2003) Tumor detection using 18F-labeled matrix metalloproteinase-2 inhibitor Nucl. Med. Biol. 30, 119-25
49. Razavian, M., Zhang, J., Nie, L., Tavakoli, S., Razavian, N., Dobrucki, L. W., Sinusas, A. J., Edwards, D. S., Azure, M., and Sadeghi, M. M. (2010) Molecular imaging of matrix metalloproteinase activation to predict murine aneurysm expansion in vivo J. Nucl. Med. 51, 1107-15
50. Scherer, R. L., VanSaun, M. N., McIntyre, J. O., and Matrisian, L. M. (2008) Optical imaging of matrix metalloproteinase-7 activity in vivo using a proteolytic nanobeacon Mol. Imaging 7, 118-31
51. Sprague, J. E., Li, W. P., Liang, K., Achilefu, S., and Anderson, C. J. (2006) In vitro and in vivo investigation of matrix metalloproteinase expression in metastatic tumor models Nucl. Med. Biol. 33, 227-37
52. Ujula, T., Huttunen, M., Luoto, P., Perakyla, H., Simpura, I., Wilson, I., Bergman, M., and Roivainen, A. (2010) Matrix metalloproteinase 9 targeting peptides: syntheses, 68Ga-labeling, and preliminary evaluation in a rat melanoma xenograft model Bioconjugate Chem. 21, 1612-21
53. Kuge, Y., Takai, N., Ogawa, Y., Temma, T., Zhao, Y., Nishigori, K., Ishino, S., Kamihashi, J., Kiyono, Y., Shiomi, M., and Saji, H. (2010) Imaging with radiolabelled anti-membrane type 1 matrix metalloproteinase (MT1-MMP) antibody: potentials for characterizing atherosclerotic plaques Eur. J. Nucl. Med. Mol. Imaging 37, 2093-104